Osteoporosis



Dental Panoramic Radiographs to Screen for Post-menopausal Osteoporosis


Condition:   Osteoporosis, Postmenopausal
Interventions:   Diagnostic Test: Dental panoramic radiograph;   Diagnostic Test: DXA
Sponsors:   University of Parma;   Queen Mary University of London
Not yet recruiting


Efficacy of Oral Ibandronate in Osteoporosis


Condition:   Osteoporosis
Interventions:   Drug: Ibandronate;   Drug: Oral Ibandronate and Vitamin D
Sponsor:   Shinshu University
Recruiting


Efficacy of Zoledronic Acid in Osteoporosis


Condition:   Osteoporosis
Interventions:   Drug: "Zoledronic acid", "Reclast®";   Drug: "Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"
Sponsor:   Shinshu University
Recruiting


Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis


Condition:   Osteoporosis
Intervention:   Drug: Zoledronic Acid
Sponsors:   Aarhus University Hospital;   University of Aarhus;   Amgen
Recruiting


Multicenter Cohort Study on Osteoporosis


Condition:   Osteoporosis
Intervention:  
Sponsors:   Shanghai University of Traditional Chinese Medicine;   Wangjing Hospital, China Academy of Chinese Medical Sciences;   Dongzhimen Hospital, Beijing;   The 309th Hospital of Chinese People's Libertation Army;   The First Affiliated Hospital, Guangzhou University of TCM;   Guangdong Provincial Hospital of Traditional Chinese Medicine;   Affliliated Hospital of Changchun University of Chinese Medicine;   Gansu Provincial Hospital;   Luoyang Zhenggu Hospital;   Guangzhou Kingmed Diagnostics Co., Ltd.
Not yet recruiting


Shock Wave Therapy for Osteoporosis


Condition:   Osteoporosis
Intervention:   Device: Unfocused extracoporeal shock wave therapy
Sponsor:   UMC Utrecht
Completed


PTH and Vibration in OSteoporosis Study


Condition:   Osteoporosis
Interventions:   Other: whole-body vibration;   Drug: teriparatide
Sponsors:   Odense University Hospital;   University of Southern Denmark;   Copenhagen University Hospital, Denmark;   Hospital of South West Denmark;   Sygehus Lillebaelt;   OPEN - Odense Patient data Explorative Network;   Region of Southern Denmark
Recruiting


Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France


Condition:   Post Menopausal Osteoporosis
Intervention:   Drug: AMG 162 - Prolia
Sponsor:   Amgen
Active, not recruiting


The Relationship Between the Residual Renal Function and Osteoporosis Treatment


Condition:   Osteoporosis
Intervention:   Drug: Bis, SERM Teriparatide, Denosumab
Sponsor:   Toshihiko Kono
Recruiting


The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab


Condition:   Osteoporosis
Interventions:   Drug: Standard Clinical Practice Regimen;   Drug: Experimental Cyclic Regimen
Sponsor:   Health Research, Inc.
Active, not recruiting


A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis


Condition:   Postmenopausal Osteoporosis
Interventions:   Drug: Romosozumab 90 mg/mL;   Drug: Placebo 90 mg/mL;   Drug: Romosozumab 70 mg/mL;   Drug: Placebo 70 mg/mL
Sponsor:   Amgen
Completed


Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAX


Condition:   Osteoporosis
Intervention:  
Sponsors:   Bone Index Finland Ltd;   Merck Sharp & Dohme Corp.
Completed


Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis


Condition:   Postmenopausal Osteoporosis (PMO)
Interventions:   Drug: Romosozumab;   Drug: Placebo
Sponsor:   Amgen
Completed


Bindex Ultrasonometer for Osteoporosis Diagnostics


Condition:   Osteoporosis
Intervention:  
Sponsors:   Bone Index Finland Ltd;   HealthEast Care System
Terminated


A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care


Condition:   Osteoporosis
Intervention:   Behavioral: Video-based Intervention
Sponsors:   University of Alabama at Birmingham;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);   University of Massachusetts, Worcester;   Helen Hayes Hospital;   Kaiser Permanente;   Cedars-Sinai Medical Center;   University of Pittsburgh;   University of Cincinnati
Completed


Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis


Condition:   Postmenopausal Women With Osteoporosis
Interventions:   Drug: Romosozumab;   Drug: Alendronate
Sponsor:   Amgen
Completed


Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis


Condition:   Postmenopausal Osteoporosis
Interventions:   Drug: Romosozumab;   Drug: Placebo;   Drug: Denosumab
Sponsor:   Amgen
Completed


Multi-joint Coordination Underlies Upright Balance Control in Elderly With Osteoporosis


Condition:   Osteoporosis
Intervention:  
Sponsor:   National Taiwan University Hospital
Completed


Osteoporosis Research Registry


Condition:   Osteoporosis
Intervention:  
Sponsors:   Northwestern University;   Shirley Ryan AbilityLab
Completed


Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis


Condition:   Osteoporosis
Intervention:   Drug: Teriparatide
Sponsor:   University Health Network, Toronto
Recruiting


A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.


Condition:   Osteoporosis
Interventions:   Drug: Ronacaleret;   Drug: Teriparatide;   Drug: Alendronate
Sponsor:   GlaxoSmithKline
Terminated


Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate


Condition:   Osteoporosis
Interventions:   Drug: Ibandronate;   Drug: Alendronate
Sponsor:   GlaxoSmithKline
Completed


A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo


Condition:   Osteoporosis
Interventions:   Drug: ibandronate;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Completed


Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis


Condition:   Osteoporosis
Intervention:   Drug: Zoledronic Acid
Sponsor:   Novartis Pharmaceuticals
Completed


A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis


Condition:   Osteoporosis
Interventions:   Drug: placebo;   Drug: Denosumab
Sponsor:   Amgen
Completed

Refine Your Search Advanced Search